MiR-200c-SUMOylated KLF4 feedback loop acts as a switch in transcriptional programs that control VSMC proliferation

Journal of Molecular and Cellular Cardiology

Volumn 82, Issue , 2015, Pages 201-212

  Zheng, Bin ^a   Bernier, Michel ^b   Zhang, Xin hua ^a   Suzuki, Toru ^c   Nie, Chan quan ^a   Li, Yong hui ^a   Zhang, Yong ^a   Song, Li li ^a   Shi, Hui jing ^a   Liu, Yan ^a   Zheng, Cui ying ^a   Wen, Jin kun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

KLF4; MiR 200c; Proliferation; SUMOylation; Ubc9; VSMC

Indexed keywords

HISTONE DEACETYLASE 2; KRUPPEL LIKE FACTOR 4; MICRORNA 200C; NUCLEAR RECEPTOR COREPRESSOR; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN UBC9; COREPRESSOR PROTEIN; HISTONE DEMETHYLASE; KDM1A PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; MICRORNA; MIRN200 MICRORNA, HUMAN; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; PROTEIN BINDING; SERUM RESPONSE FACTOR; SRF PROTEIN, HUMAN; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN-CONJUGATING ENZYME UBC9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY MUSCLE; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; EXPERIMENTAL BALLOON CATHETER INJURY; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN CELL; HYPERPLASIA; IN VIVO STUDY; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RESTENOSIS; SMOOTH MUSCLE FIBER; SUMOYLATION; TRANSCRIPTION REGULATION; BIOLOGICAL MODEL; CELL CULTURE; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

CELL PROLIFERATION; CELLS, CULTURED; CO-REPRESSOR PROTEINS; DOWN-REGULATION; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE 2; HISTONE DEMETHYLASES; HUMANS; HYPERPLASIA; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MAP KINASE SIGNALING SYSTEM; MICRORNAS; MODELS, BIOLOGICAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-SIS; RNA INTERFERENCE; SERUM RESPONSE FACTOR; SUMOYLATION; TRANSCRIPTION, GENETIC; UBIQUITIN-CONJUGATING ENZYMES;

EID: 84925946723     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.03.011     Document Type: Article

References (45)

1. Kawai-Kowase K., Ohshima T., Matsui H., Tanaka T., Shimizu T., Iso T., et al. PIAS1 mediates TGFbeta-induced SM alpha-actin gene expression through inhibition of KLF4 function-expression by protein sumoylation. Arterioscler Thromb Vasc Biol 2009, 29:99-106.
2. Wang C., Zhang Y., Yang Q., Yang Y., Gu Y., Wang M., et al. A novel cultured tissue model of rat aorta: VSMC proliferation mechanism in relationship to atherosclerosis. Exp Mol Pathol 2007, 83:453-458.
3. Coinu R., Chiaviello A., Galleri G., Franconi F., Crescenzi E., Palumbo G. Exposure to modeled microgravity induces metabolic idleness in malignant human MCF-7 and normal murine VSMC cells. FEBS Lett 2006, 580:2465-2470.
4. Satoh K., Nigro P., Matoba T., O'Dell M.R., Cui Z., Shi X., et al. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med 2009, 15:649-656.
5. Wassmann S., Wassmann K., Jung A., Velten M., Knuefermann P., Petoumenos V., et al. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells. J Mol Cell Cardiol 2007, 43:301-307.
6. Fabian M.R., Sonenberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 2012, 19:586-593.
7. Davis-Dusenbery B.N., Chan M.C., Reno K.E., Weisman A.S., Layne M.D., Lagna G., et al. Down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4. J Biol Chem 2011, 286:28097-28110.
8. Cheng Y., Liu X., Yang J., Lin Y., Xu D.Z., Lu Q., et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009, 105:158-166.
9. Liu X., Cheng Y., Zhang S., Lin Y., Yang J., Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009, 104:476-487.
10. Sun S.G., Zheng B., Han M., Fang X.M., Li H.X., Miao S.B., et al. miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep 2011, 12:56-62.
11. Liu X., Cheng Y., Chen X., Yang J., Xu L., Zhang C. MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2. J Biol Chem 2011, 286:42371-42380.
12. Zhang Y., Wang Y., Wang X., Eisner G.M., Asico L.D., Jose P.A., et al. Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21. J Hypertens 2011, 29:1560-1568.
13. Rokavec M., Wu W., Luo J.L. IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis. Mol Cell 2012, 45:777-789.
14. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008, 10:593-601.
15. Kiyan Y., Limbourg A., Kiyan R., Tkachuk S., Limbourg F.P., Ovsianikov A., et al. Urokinase receptor associates with myocardin to control vascular smooth muscle cells phenotype in vascular disease. Arterioscler Thromb Vasc Biol 2012, 32:110-122.
16. Wu F., Zhu S., Ding Y., Beck W.T., Mo Y.Y. MicroRNA-mediated regulation of Ubc9 expression in cancer cells. Clin Cancer Res 2009, 15:1550-1557.
17. Martin S., Nishimune A., Mellor J.R., Henley J.M. SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature 2007, 447:321-325.
18. Oishi Y., Manabe I., Tobe K., Ohsugi M., Kubota T., Fujiu K., et al. SUMOylation of Kruppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta. Nat Med 2008, 14:656-666.
19. Du J.X., Bialkowska A.B., McConnell B.B., Yang V.W. SUMOylation regulates nuclear localization of Kruppel-like factor 5. J Biol Chem 2008, 283:31991-32002.
20. Khanna-Gupta A. Sumoylation and the function of CCAAT enhancer binding protein alpha (C/EBP alpha). Blood Cells Mol Dis 2008, 41:77-81.
21. Papapetrou E.P., Tomishima M.J., Chambers S.M., Mica Y., Reed E., Menon J., et al. Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci U S A 2009, 106:12759-12764.
22. Gamper A.M., Qiao X., Kim J., Zhang L., DeSimone M.C., Rathmell W.K., et al. Regulation of KLF4 turnover reveals an unexpected tissue-specific role of pVHL in tumorigenesis. Mol Cell 2012, 45:233-243.
23. Zhang X.H., Zheng B., Gu C., Fu J.R., Wen J.K. TGF-beta1 downregulates AT1 receptor expression via PKC-delta-mediated Sp1 dissociation from KLF4 and Smad-mediated PPAR-gamma association with KLF4. Arterioscler Thromb Vasc Biol 2012, 32:1015-1023.
24. Tetreault M.P., Wang M.L., Yang Y., Travis J., Yu Q.C., Klein-Szanto A.J., et al. Klf4 overexpression activates epithelial cytokines and inflammation-mediated esophageal squamous cell cancer in mice. Gastroenterology 2010, 139:2124-2134.
25. Yoshida T., Kaestner K.H., Owens G.K. Conditional deletion of Kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res 2008, 102:1548-1557.
26. Zheng B., Han M., Bernier M., Zhang X.H., Meng F., Miao S.B., et al. Kruppel-like factor 4 inhibits proliferation by platelet-derived growth factor receptor beta-mediated, not by retinoic acid receptor alpha-mediated, phosphatidylinositol 3-kinase and ERK signaling in vascular smooth muscle cells. J Biol Chem 2009, 284:22773-22785.
27. Pidkovka N.A., Cherepanova O.A., Yoshida T., Alexander M.R., Deaton R.A., Thomas J.A., et al. Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res 2007, 101:792-801.
28. Yu K., Zheng B., Han M., Wen J.K. ATRA activates and PDGF-BB represses the SM22alpha promoter through KLF4 binding to, or dissociating from, its cis-DNA elements. Cardiovasc Res 2011, 90:464-474.
29. Gomez D., Owens G.K. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 2012, 95:156-164.
30. Shi J.H., Zheng B., Chen S., Ma G.Y., Wen J.K. Retinoic acid receptor alpha mediates All-trans-retinoic acid-induced Klf4 gene expression by regulating Klf4 promoter activity in vascular smooth muscle cells. J Biol Chem 2012, 287:10799-10811.
31. Yoshida T., Sinha S., Dandre F., Wamhoff B.R., Hoofnagle M.H., Kremer B.E., et al. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res 2003, 92:856-864.
32. McDonald O.G., Wamhoff B.R., Hoofnagle M.H., Owens G.K. Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J Clin Invest 2006, 116:36-48.
33. Rebustiniv I.T., Hayashi T., Reynolds A.D., Dillard M.L., Carpenter E.M., Hoffman M.P. miR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesis. Development 2012, 139:20-191.
34. Liu S., Tetzlaff M.T., Cui R., Xu X. miR-200c inhibits melanoma progression and drug resistance through down-regulation of Bmi-1. Am J Pathol 2012, 181:1823-1835.
35. Hur K., Toiyama Y., Takahashi M., Balaguer F., Nagasaka T., Koike J., et al. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut 2013, 62:1315-1326.
36. Wei D., Kanai M., Jia Z., Le X., Xie K. Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res 2008, 68:4631-4639.
37. Shie J.L., Chen Z.Y., Fu M., Pestell R.G., Tseng C.C. Gut-enriched Kruppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res 2000, 28:2969-2976.
38. Chen Z.Y., Shie J.L., Tseng C.C. Gut-enriched Kruppel-like factor represses ornithine decarboxylase gene expression and functions as checkpoint regulator in colonic cancer cells. J Biol Chem 2002, 277:46831-46839.
39. Qin Y., Xu J., Aysola K., Begum N., Reddy V., Chai Y., et al. Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins. J Cell Physiol 2011, 226:3355-3367.
40. Guo Y., Yang M.C., Weissler J.C., Yang Y.S. Modulation of PLAGL2 transactivation activity by Ubc9 co-activation not SUMOylation. Biochem Biophys Res Commun 2008, 374:570-575.
41. Kurtzman A.L., Schechter N. Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification. Proc Natl Acad Sci U S A 2001, 98:5602-5607.
42. Sun Y., Tao Y.G., Kagan B.L., He Y., Jr S.S. Modulation of transcription parameters in glucocorticoid receptor-mediated repression. Mol Cell Endocrinol 2008, 295:59-69.
43. Sentis S., Le Romancer M., Bianchin C., Rostan M.C., Corbo L. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Mol Endocrinol 2005, 19:2671-2684.
44. Kampmann U., Christensen B., Nielsen T.S., Pedersen S.B., Orskov L., Lund S. GLUT4 and UBC9 protein expression is reduced inmuscle fromtype 2 diabetic patients with severe insulin resistance. PLoS One 2011, 6:e27854.
45. Du J.X., McConnell B.B., Yang V.W. A small ubiquitin-related modifier-interacting motif functions as the transcriptional activation domain of Kruppel-like factor 4. J Biol Chem 2010, 285:28298-28308.